NEUE 2',3'-METHYLIDENACETYLADENOSINE PRODRUGS ZUR VERWENDUNG ALS ADENOSINREZEPTORAGONISTEN

The invention relates to a method of improving oral drug absorption of adenosine analogues by the use of 2′,3′-methylidene acetal adenosine pro-drugs and to the use of these pro-drugs as medicaments. The invention further relates to compounds that are pro-drugs of adenosine receptor agonists, and to...

Full description

Saved in:
Bibliographic Details
Main Author SAVORY, EDWARD DANIEL
Format Patent
LanguageGerman
Published 15.03.2011
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a method of improving oral drug absorption of adenosine analogues by the use of 2′,3′-methylidene acetal adenosine pro-drugs and to the use of these pro-drugs as medicaments. The invention further relates to compounds that are pro-drugs of adenosine receptor agonists, and to their use as therapeutic compounds, in particular as analgesic or anti-inflammatory compounds, or as disease modifying antirheumatic drugs (DMARDs), and to methods of preventing, treating or ameliorating pain or inflammation using these compounds.
Bibliography:Application Number: AT20070765638T